This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The report also touts, as more evidence, Illinois’ $2,007,401,374 in sales during the past fiscal year. IDFPR is also committed to working with those who received Conditional Adult Use Dispensing Organization licenses in 2023’s Social Equity Criteria Lottery to open their doors as new dispensaries and begin serving customers.
Friday, the Illinois Department of Financial & Professional Regulation (IDFPR) released its Annual Cannabis Report for fiscal year 2023. The 20-page report included a summary, 2023 accomplishments, goals for fiscal year 2024, and several charts and statistics. This goal was again listed as one of the Essential Projects for FY2024.
Four Illinois House bills involving cannabis oversight and regulations were assigned to the Executive Committee February 28, 2023. Effective July 1, 2023.” was filed on January 25, 2023, assigned to the Rules Committee January 25, 2023, and then assigned to the Executive Committee February 28, 2023. Evans, Jr. ,
The state allows the sale and use of CBD products with 0% THC. Growers must apply for a license through the state and can only use state-approved seeds. At the end of the 2022 legislative session, lawmakers voted to form a committee dedicated to exploring the creation of a program for the 2023 legislative session. THC or less.
Conditional Adult-Use Retail Dispensary Regulations. During the meeting, the CCB directed the OCM to post for public comment the proposed regulations for the conditional adult-use retail dispensary licenses to businesses run by owners disproportionately impacted by the criminalization of cannabis.
Allowed formats include flowers, concentrates, edibles, transdermal products, seeds, and seedlings.” On July 6, 2022, Washington, D.C. implemented a revolutionary emergency amendment to its medical cannabis program. The Medical Marijuana Self-Certification Temporary Amendment Act of 2022 currently permits D.C. These changes to D.C.’s
It emerges from the 2018-2023 coalition agreement that legislation on recreational cannabis will be drafted ( 2018-2023 Coalition Agreement ) . On the one hand, it is proposed that adults should be able to legally cultivate for personal consumption up to four cannabis plants per household from seeds. Project modalities.
However, the relationship between these two agricultural enterprises has leaned more toward its complicated than one would expect, as legal and cultural clashes progressively seed deep conflicts between producers of the profitable commodities.
The Notes were offered for sale on a private placement basis in certain provinces of Canada pursuant to applicable exemptions from the prospectus requirements of Canadian securities laws. NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. NEW YORK–(BUSINESS WIRE)–Columbia Care Inc.
The Transaction is expected to achieve cost synergies through combining activities in supply chain and distribution, research, and product development, as well as cost reductions in sales, general and administrative activities, and general overhead. The Green Organic Dutchman Holdings Ltd. Galaxie’s 26,000 sq. production capabilities.
Kathy Hochul announced June 22 the selection of Social Equity Impact Ventures LLC, a minority-led investment team, to sponsor and manage New York’s $200-million Social Equity Cannabis Investment Program that was included in the state’s fiscal 2023 enacted state budget. Cannabis Business Times.
Total upfront consideration was approximately $240 million, comprised of $45 million in cash and $195 million in Columbia Care stock, with the potential for additional performance-based milestones in 2022 and 2023. 2021 Adjusted EBITDA. This transaction is immediately accretive to gross margin, Adjusted EBITDA and cash flow from operations.
The Transaction is scheduled to close on or about November 15, 2021 , and subject to customary closing conditions and covenants. TGOD to acquire Galaxie Brands Corporation. Acquisition significantly expands and diversifies TGOD’s product portfolio through: Galaxie’s exclusive joint venture in Canada , with a major U.S.
26 with approximately 10,000 hemp seeds planted in a single day. The Company has executed a sales agreement to sell $1 million worth of DrillWall over the course of one year. (Read the full press release here.) . CEO Bruce Perlowin’s role as the subject of the No. 1 most watched CNBC documentary of all time “Marijuana Inc.”. “In
million of the Company’s existing 13% senior secured notes due 2023, pursuant to private agreements in accordance with the trust indenture, for an equivalent amount of 2026 Notes plus accrued but unpaid interest and any negotiated premium thereon. persons (as defined in Regulation S under the U.S. About Columbia Care.
Cannabis NYC will plant the seeds for the economy of tomorrow by helping New Yorkers apply for licenses and understand how to open and successfully run a business, while simultaneously rolling equity into our economy by giving those who have been justice-involved and those with a cannabis conviction a chance to succeed.
Legislators seem both wary and weary of cannabis: the 2023 industry scandals implicating public officials are still fairly recent; and, after ten dynamic years and hundreds of adult use cannabis proposals, bills and laws, the program needs to breathe. But first Ill add my usual caveat: a large majority of these introduced bills will not pass.
The law authorizes doctors to prescribe cannabis for a long list of specific qualifying conditions, as well as any condition the doctor “considers debilitating to an individual patient” that the doctor “is qualified through [their] medical education and training to treat.” Hunter Robinson. Whitt Steineker. Slates Veazey.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content